Chronic hepatitis c virus (hcv) infection

Chronic Hepatitis C is a long-term viral infection that affects the liver. It is caused by the Hepatitis C Virus (HCV), which is transmitted primarily through contact with the blood of an infected person. The infection can lead to chronic liver disease, cirrhosis, liver failure, and liver cancer.
Treatment options for chronic HCV infection have significantly improved in recent years. Antiviral medications, such as direct-acting antivirals (DAAs), are commonly used in combination to target the HCV virus and clear the infection from the body. Commonly prescribed DAA-based regimens include Harvoni (ledipasvir/sofosbuvir), Epclusa (sofosbuvir/velpatasvir), and Mavyret (glecaprevir/pibrentasvir). These medications are typically taken for a fixed duration of 8-12 weeks, depending on the specific regimen and patient characteristics.
Consult with a healthcare professional to determine the most suitable treatment plan based on individual factors, such as viral genotype, liver function, and presence of other medical conditions. Regular monitoring of liver function is necessary during treatment to ensure patient safety and optimize treatment outcomes.